FDA Wants Antidepressant Makers to Update Suicide Warnings

WASHINGTON, D.C. - The FDA wants all U.S. manufacturers of antidepressants to add new precautions to their already high-profile warning labels, indicating an increased risk of suicidality in young adults who take the drugs.

The announcement came May 2, less than two years after similar labeling changes by the drug makers highlighted the suicidality risk posed to young children and adolescents who are prescribed antidepressant drugs.

According to the FDA, the new recommended warnings would bolster already stringent "black box warnings" placed on the products in 2005, and follow a recommendation by the agency's Psychopharmacologic Drugs Advisory Committee, which agreed …